DealMatrix
VALUATION I SCOUTING I MATCHING
DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings.
29/07/2026
🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #30: Humanoid Series A: Humanoid Raises $152M, Hits $1.35B Valuation
Humanoid, a UK-based AI and robotics company developing industrial humanoid robots, has announced a $152 million Series A funding round at a $1.35 billion post-money valuation, bringing its total capital raised to $270 million.
The round was led by Prime Movers Lab, with participation from Schaeffler, Bosch, Fubon Financial Holding Venture Capital and AGLAÉ VENTURES. The financing underscores strong investor confidence in Humanoid's rapid ex*****on and the increasing commercial potential of industrial humanoid robotics.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
Humanoid operates in the Robotics and Artificial Intelligence sectors, developing wheeled and bipedal industrial humanoid robots and the proprietary KinetIQ AI system that runs them.
DealMatrix benchmarks (Q2 2026) for Series A robotics, automation, and artificial intelligence companies indicate valuation ranges of EV/Sales multiples of 6.25x-13.28x and EV/EBITDA multiples of 40.76x-59.85x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Multiples Platform at https://platform.dealmatrix.com
20/07/2026
🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #29: Helsing Series E: European defencetech leader secures $1.8B at $18B valuation
Helsing has raised USD 1.8 billion in a Series E financing round, valuing the European defence AI company at USD 18 billion post-money.
The round attracted both new and existing investors, including Dragoneer Investment Group, Lightspeed Venture Partners, Disruptive, Iconiq, Growth Equity at Goldman Sachs Alternatives, JPMorganChase, Canada Pension Plan Investment Board (CPP Investments), General Catalyst, Plural, and StepStone.
Investor demand significantly exceeded the available allocation, highlighting strong market confidence in AI-driven and software-defined defence technologies.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
Helsing operates in the Defence Technology and Artificial Intelligence sectors, developing AI software and autonomous systems for military and national security applications across Europe.
DealMatrix benchmarks (Q1 2026) for Series E artificial intelligence, drones, and data and analytics companies indicate valuation ranges of EV/Sales multiples of 1.82x–3.58x and EV/EBITDA multiples of 9.31x–14.78x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Multiples Platform at https://platform.dealmatrix.com
01/07/2026
🔥Our Deal of the Month June/26 is NEURA Robotics
Neura Robotics, a German robotics company specializing in humanoid systems, has secured a major Series C funding round backed by a mix of leading U.S. technology firms and European industrial investors.
The round, which raised up to $1.4 billion, attracted participation from Tether.io, Qualcomm, Amazon, NVIDIA, Bosch, Schaeffler, and the European Investment Bank (EIB).
According to a person familiar with the transaction, who spoke on condition of anonymity because they were not authorized to discuss the matter publicly, the financing values Neura Robotics at approximately $7 billion. The company declined to comment on its valuation.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
NEURA Robotics operates in the Robotics, Artificial Intelligence (AI), and Industrial Automation sectors, developing cognitive robots that enable safe and intelligent human-robot collaboration across industrial and service environments.
Given the company’s current Series C stage, European benchmarks (Q1 2026) for Robotics and AI companies indicate valuation ranges of EV/Sales multiples of 1.54x–3.76x and EV/EBITDA multiples of 10.19x–16.84x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com
29/06/2026
🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #26: Berlin Drone-Maker STARK Raises €500m at a €3.5bn-Plus Valuation in a Sequoia and Founders Fund Round
STARK, the Berlin-based loitering munition startup founded in 2024, announced a €500 million Series C funding round on 23 June 2026, tripling its valuation to over €3.5 billion.
The round was co-led by Sequoia Capital and Peter Thiel's Founders Fund, with participation from the NATO Innovation Fund (NIF), Döpfner Capital, Project A, and other investors.
Following the raise, STARK's total funding has reached approximately €640 million, underscoring its rapid growth as one of Europe's most highly valued defense technology companies.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
STARK develops AI-enabled drones for Germany and allied militaries. Its flagship product, Virtus, is a long-range loitering munition designed for autonomous target identification and precision strikes.
Across Drones, Artificial Intelligence, and Software, European benchmarks (Q1 2026, as of 31 March 2026) for these sectors indicate:
Drones: EV/Sales 2.04x, EV/EBITDA 11.01x
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Multiples Platform at https://platform.dealmatrix.com
24/06/2026
Everyone calls private-market data "thin."
The real problem is worse than thin.
Out of 100 private deals, only a handful ever disclose a valuation, and fewer still disclose real financials.
The few that do rarely match the stage, region or industry of the company you're actually trying to value.
So you end up anchoring a number on three or four loosely comparable deals and hoping they're close enough.
Below 1B in enterprise value, or in a niche sector, that sample basically runs out.
That's exactly the gap we built DealMatrix to close.
Rather than relying on comparable private deals that may not exist, we statistically capture how valuation behaves across the market and translate that to private companies.
➡️ EV/Sales & EV/EBITDA multiples categorized by industry, stage and region grounded in established financial theory rather than rules of thumb.
A derived benchmark, not a comp with a discount.
How thin does the data get in the sectors you work in, and what do you fall back on when the comps run out?
22/06/2026
🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #25: Conduct Raises $60 Million Series A Round from Index, ICONIQ, and SAP
Conduct has secured a $60 million Series A funding round co-led by Index Ventures and ICONIQ, with strategic backing from SAP and participation from existing investors Creandum, Lucid Capital, and BOOOM💥.
The company is building an AI-powered operating system designed to help enterprises understand, manage, and transform the increasingly complex software environments they depend on.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
Conduct AI operates in the Enterprise Software, AI, and IT sectors, developing an AI-native platform that helps enterprises understand, operate, and modernise complex software systems.
Given the company’s current Series A stage, European benchmarks (Q1 2026) for AI and enterprise software companies indicate valuation ranges of EV/Sales multiples of 3.42x–3.87x and EV/EBITDA multiples of 16.32x–18.66x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Multiples Platform at https://platform.dealmatrix.com
17/06/2026
This morning the whole team gathered to watch Austria's World Cup match.
There was shouting, there was at least one spilled drink, and at the end of it, Austria won.
Now, we're an Austrian company. And a win like that deserves to be celebrated properly, so we're doing it the only way we know how.
So here's the logic: three goals went in, so we're giving away three licenses. We will be quietly ignoring the small detail that one of those goals was an own goal.
Here's the actual offer:
3 DealMatrix Professional licenses, €149 each instead of €490. That's the full platform, 15,000+ private-market multiples across 140+ industries, stage and region adjusted, with raw data export included.
The same thing funds and M&A teams use to anchor valuations they can actually defend in an IC memo, just at a price we'll probably regret by tomorrow.
Three goals, three licenses, first come first served. Once they're in the back of the net, that's full time.
Code "AUSTRIA3" at checkout 👉 https://dealmatrix.com/multiples/
15/06/2026
🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #24: NEURA Robotics raises up to $1.4 billion from Nvidia, Amazon and others
U.S. tech giants have participated in a major funding round for a German robotics company focused on humanoid systems.
Neura Robotics’ Series C round, valued at up to $1.4 billion, included investors such as Tether.io, Qualcomm, Amazon, and NVIDIA, alongside European industrial players Bosch and Schaeffler, as well as the European Investment Bank (EIB).
According to a source familiar with the transaction who requested anonymity due to lack of authorization to speak publicly, the company is now valued at approximately $7 billion. Neura Robotics declined to comment on the reported valuation.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
NEURA Robotics operates in the Robotics, Artificial Intelligence (AI), and Industrial Automation sectors, developing cognitive robots that enable safe and intelligent human-robot collaboration across industrial and service environments.
Given the company’s current Series C stage, European benchmarks (Q1 2026) for Robotics and AI companies indicate valuation ranges of EV/Sales multiples of 1.54x–3.76x and EV/EBITDA multiples of 10.19x–16.84x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com
08/06/2026
🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #23: Factorial Raises $150M Series D, Reaches $2.5 Billion Valuation to Become One of the Most Valuable AI Scale-Ups in Europe
Europe’s leading AI-powered workforce operations platform today announced the successful close of a $150 million Series D funding round, valuing the company at $2.5 billion and positioning it among the most valuable scale-ups in Spain and across Europe.
The round was led by General Catalyst, marking its first equity investment in Factorial, with participation from existing investors including Atomico and Four Rivers. In addition to its equity commitment, General Catalyst is expanding its support through its Customer Value Fund, committing up to an additional $540 million. This brings the total capital committed to more than $700 million, providing substantial resources to accelerate Factorial’s growth and expansion in the years ahead.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
Factorial operates in the HR Technology (HR Tech) and SaaS sectors, providing a cloud-based platform that helps businesses manage core HR processes, including employee administration, time tracking, payroll, and performance management.
Given the company’s current Series D stage, European benchmarks (Q1 2026) for HR Tech and SaaS companies indicate valuation ranges of EV/Sales multiples of 3.47x–4.30x and EV/EBITDA multiples of 18.66x–20.22x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com
03/06/2026
🔥Our Deal of the Month May/26 is Isomorphic Labs
Isomorphic Labs, an AI-native drug discovery and development company, has announced a $2.1 billion Series B funding round aimed at accelerating the transition from breakthrough AI research to large-scale real-world drug development applications.
The round was led by Thrive Capital, with participation from existing investors Alphabet Inc. and GV (Google Ventures), alongside new backers including MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, further strengthening the company’s international investor base.
👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!
Isomorphic Labs operates at the intersection of biotechnology, artificial intelligence, and pharmaceuticals, with a focus on accelerating drug discovery through advanced AI models and computational life sciences research. Given the company’s current Series B stage, European benchmarks (Q1 2026) for AI-enabled biotechnology and pharmaceutical businesses indicate ⤵️
Valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 16.84x - 20.68x.
➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com
Klicken Sie hier, um Ihren Gesponserten Eintrag zu erhalten.
Kategorie
Service kontaktieren
Webseite
Adresse
Babenbergerstrasse 9
Vienna
1010
Öffnungszeiten
| Montag | 09:00 - 17:00 |
| Dienstag | 09:00 - 17:00 |
| Mittwoch | 09:00 - 17:00 |
| Donnerstag | 09:00 - 17:00 |
| Freitag | 09:00 - 17:00 |